EP 1615631 A2 20060118 - USE OF L-DOPA, DERIVATIVES THEREOF AND MEDICAMENTS COMPRISING SAID COMPOUNDS FOR THE PROPHYLAXIS OF PSYCHOTIC DISEASES
Title (en)
USE OF L-DOPA, DERIVATIVES THEREOF AND MEDICAMENTS COMPRISING SAID COMPOUNDS FOR THE PROPHYLAXIS OF PSYCHOTIC DISEASES
Title (de)
VERWENDUNG VON L-DOPA, SEINER DERIVATE UND DIESE VERBINDUNGEN ENTHALTENDER ARZNEIMITTEL ZUR PROPHYLAXE PSYCHOTISCHER ERKRANKUNGEN
Title (fr)
UTILISATION DE L-DOPA, DE SES DERIVES ET DE MEDICAMENTS CONTENANT LESDITS COMPOSES POUR LA PROPHYLAXIE DE MALADIES PSYCHOTIQUES
Publication
Application
Priority
- DE 0304204 W 20031218
- DE 10261808 A 20021219
Abstract (en)
[origin: WO2004056306A2] The invention relates to the use of L-DOPA, the derivatives or pharmacologically-acceptable salts thereof for the prophylaxis of psychotic diseases and for the treatment of diseases caused by disturbed tyrosine transport or disturbed tyrosine decarboxylase. The invention further relates to pharmaceutical compositions which contain L-DOPA, the derivatives or pharmacologically-acceptable salts thereof for the prophylaxis of psychotic diseases along with pharmacologically-acceptable auxiliaries and adjuncts and, furthermore, the combination of L-DOPA, the derivatives or pharmacologically-acceptable salts thereof with enzyme inhibitors for the prophylaxis of psychotic diseases and for the treatment of diseases caused by disturbed tyrosine transport or disturbed tyrosine decarboxylase and the corresponding pharmaceutical compositions for the prophylaxis of psychotic diseases and for the treatment of diseases caused by disturbed tyrosine transport or disturbed tyrosine decarboxylase.
IPC 1-7
IPC 8 full level
A61K 31/198 (2006.01); A61K 31/135 (2006.01); A61K 31/137 (2006.01); A61K 31/175 (2006.01); A61K 31/195 (2006.01); A61K 31/435 (2006.01); A61P 25/00 (2006.01); A61P 25/18 (2006.01)
CPC (source: EP)
A61K 31/135 (2013.01); A61K 31/137 (2013.01); A61K 31/175 (2013.01); A61K 31/195 (2013.01); A61K 31/198 (2013.01); A61K 31/435 (2013.01); A61P 25/00 (2017.12); A61P 25/18 (2017.12); A61P 43/00 (2017.12)
Citation (search report)
See references of WO 2004056306A2
Designated contracting state (EPC)
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT RO SE SI SK TR
Designated extension state (EPC)
LV MK
DOCDB simple family (publication)
WO 2004056306 A2 20040708; WO 2004056306 A3 20041111; AU 2003294664 A1 20040714; CA 2513077 A1 20040708; CN 1756542 A 20060405; DE 10261808 A1 20040708; EA 200500957 A1 20060224; EP 1615631 A2 20060118; JP 2006511558 A 20060406; MX PA05006409 A 20060531; PL 377524 A1 20060206
DOCDB simple family (application)
DE 0304204 W 20031218; AU 2003294664 A 20031218; CA 2513077 A 20031218; CN 200380106614 A 20031218; DE 10261808 A 20021219; EA 200500957 A 20031218; EP 03785594 A 20031218; JP 2004561055 A 20031218; MX PA05006409 A 20031218; PL 37752403 A 20031218